Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G Open To M&A Moves, Closed To Board Seat For Activist Investor

Executive Summary

P&G posts 2% organic growth in its latest quarter and its adjusted EPS beat analyst expectations as it is again interested in M&A. A few days after releasing its results, company appeals to shareholders to vote against an activist investor's bid for a board seat.


Related Content

Activist Investor Forces P&G's Hand: Shareholder Vote On Joining Board
'Slow-Growth' Global Trend Shakes Up P&G Product Strategy Start To Finish
P&G Portfolio Rationalization Brushes Off 20% Of Oral Care SKUs
P&G Keeps Direct-to-Consumer In Perspective, Retail Distribution Primary
P&G Focuses On Consumer Health, “Deemphasizes” Pharma


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts